Result

Pharmaceutical Birth Defect Litigation | $17 Million Settlement

What Happened

Several families came to us after living through every parent’s worst nightmare, learning that their children had been born with severe birth defects after the mothers had taken a commonly prescribed medication during pregnancy.

They wanted answers. What caused this? Could it have been prevented? And why had no one warned them?

Our investigation uncovered troubling evidence: the drug manufacturer had long known of data suggesting an increased risk of congenital abnormalities but failed to give adequate warnings to doctors or patients. For years, expectant mothers were reassured that the drug was safe, and their children paid the price.

How We Fought for Them

This was not an ordinary case. It required a deep dive into cutting-edge medical science, epidemiology, and statistical analysis, and the persistence to stand toe-to-toe with the pharmaceutical industry’s global defense teams.

We took on a docket of cases and pushed the science further than it had ever been tested in court.

• We conducted dozens of expert and scientist depositions across multiple disciplines, including genetics, pharmacology, embryology, and biostatistics.
• We worked with leading specialists to explain, in precise scientific terms, how the drug’s mechanism of action could disrupt fetal development.
• We dissected the industry’s “alternative cause” defenses, including claims that the birth defects were genetic, by mastering the statistics ourselves and showing that the data didn’t support their position.

At one point, we conducted a three-day trial solely on the admissibility of the scientific evidence. The court heard from both sides’ experts, reviewed the published studies, and ruled that our scientific case was sound and admissible, a pivotal moment that reshaped the entire litigation.

What followed was intense, high-stakes negotiation grounded in both science and accountability. We made it clear: the company could continue denying responsibility, or it could begin to make things right.

The Result

The case ultimately resolved for $17 million, providing financial security for the affected children and their families, and public recognition that the harm they endured was real, preventable, and caused by corporate negligence.

The settlement came only after years of scientific trench warfare, complex litigation, and a willingness to learn the science inside and out. It remains one of the largest recoveries of its kind involving claims of birth defects linked to medication use during pregnancy.

Why This Case Matters

This case is about more than compensation: it’s about truth through science.
When large corporations rely on complexity to hide accountability, the only answer is persistence and mastery. We learned the science ourselves, deconstructed their data, and showed that the facts supported what these families already knew in their hearts: this drug caused their children’s injuries.

It’s also a case that highlights what makes our firm different, the willingness to dig into scientific journals, challenge experts on their own ground, and fight for families who deserve answers.

For these parents, the result meant stability and recognition. For the industry, it was a reminder that science doesn’t belong only to corporations, it belongs to the truth.

Related Case Types

• Pharmaceutical & Product Liability
• Birth Defect & Toxic Exposure Cases
• Catastrophic Injury & Lifelong Disability

If your child has been harmed by a defective or unsafe drug, Greenberg Streich, PLLC has the experience and resolve to take on complex scientific cases and win.

???? Call 832-583-3471 or reach out online to speak confidentially with our team.